An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population

Irish Journal of Medical Science

Volumn 178, Issue 2, 2009, Pages 161-166

  Waterhouse, Deirdre F ^a   McLaughlin, Anne M ^a   Sheehan, Frances ^b   O'Shea, D ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b Blackrock Clinic Ireland   (Ireland)

Author keywords

ATP III criteria; IDF criteria; Lifestyle modification; Metabolic syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTERNATIONAL DIABETES FEDERATION; IRELAND; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; THIRD REPORT OF THE NATIONAL CHOLESTEROL EDUCATION PROGRAM EXPERT PANEL ON DETECTION EVALUATION AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS; WAIST CIRCUMFERENCE; AGED; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; HEALTH STATUS INDICATOR; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; STATISTICS;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS INDICATORS; HUMANS; IRELAND; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC;

EID: 67649509873     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-008-0269-1     Document Type: Article

References (29)

1. Isomaa B, Almgren P, Tuomi T et al (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689. doi: 10.2337/diacare.24.4.683
2. Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle aged men. JAMA 288:2709-2716. doi: 10.1001/jama.288.21.2709
3. Trevisan M, Liu J, Bahsas FB, Menotti A (1998) Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 148:958-966
4. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM (2004) Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27:2676-2681. doi: 10.2337/diacare.27.11.2676
5. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553. doi: 10.1002/ (SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
6. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497. doi: 10.1001/ jama.285.19.2486
7. National Institutes of Health Executive summary (2001) In: Third Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Washington, DC, US Govt. Printing Office (NIH publ. no. 01-3670)
8. Ford ES (2004) Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33:333-350. doi: 10.1016/j.ecl.2004.03.004
9. The IDF consensus worldwide definition of the metabolic syndrome (2005) Available from http://www.idf.org/webdata/docs/ (article online)
10. Tenenbaum A, Motro M, Schwammenthal E, Fisman E (2004) Macrovascular complications of metabolic syndrome: An early intervention is imperative. Int J Cardiol 97:167-172. doi: 10.1016/j.ijcard.2003.07.033
11. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847
12. Conroy RM, Pyorala K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 24:987-1003. doi: 10.1016/S0195-668X(03)00114-3
13. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP (2005) The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 21:1157-1159. doi: 10.1185/030079905X53333
14. Guerrero-Romero F, Rodriguez-Moran M (2005) Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 28:2588-2589. doi: 10.2337/diacare.28.10.2588a Letter
15. Ford ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28:2745-2749. doi: 10.2337/diacare.28.11.2745
16. Lorenzo C, Serrano-Rios M, Mt Martinez-Larrad et al (2006) Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 29:685-691. doi: 10.2337/diacare.29.03.06.dc05-1796
17. Sauerwein HP (2006) The dysmetabolic syndrome: Epidemiology and etiology. Nestle Nutr Workshop Ser Clin Perform Programme 11:1-13. doi: 10.1159/000094397
18. Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A, GREECE-METS Collaborative Group (2007) Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 117(2):204-210
19. Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P et al (2006) Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29:901-907. doi: 10.2337/diacare.29.04.06.dc05-2011
20. Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation 112:e285-e290. doi: 10.1161/CIRCULATIONAHA.105.169405
21. Alberti KGMM, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome - a new worldwide definition. Lancet 366:1059-1062. doi: 10.1016/S0140-6736(05)67402-8
22. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469-480. doi: 10.1111/j.1464-5491.2006.01858.x
23. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM (2007) Harmonizing the definition of the metabolic syndrome: Comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States. American and European populations 99(4):541-548
24. Joint British recommendations on prevention of coronary heart disease in clinical practice (1998) British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society, British Diabetic Association. Heart 80(suppl 2):S1-S29
25. Preventing coronary heart disease in high risk patients (2000) In: National service framework for coronary heart disease. Department of Health, London, pp 1-32
26. Zarich S, Luciano C, Hulford J, Abdullah A (2006) Prevalence of metabolic syndrome in young patients with acute MI: Does the Framingham Risk Score underestimate cardiovascular risk in this population? Diab Vasc Dis Res 3:103-107
27. DECODE Study Group (2007) Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. Eur J Cardiovasc Prev Rehabil 14:192-199
28. Lawlor DA, Smith GD, Ebrahim S (2006) Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49:41-48
29. Wilson PAW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847